Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc. - SIC # 2840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2840
www.abbvie.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc.
AbbVie (ABBV) Stock Weighs DCF Upside Against Elevated P/E At US$227.73
- Jun 13th, 2026 8:09 am
3 Ridiculously Cheap Healthcare Stocks to Buy in June
- Jun 13th, 2026 7:30 am
Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years
- Jun 13th, 2026 6:02 am
AbbVie (ABBV) Rises Higher Than Market: Key Facts
- Jun 12th, 2026 3:45 pm
What Could Push JNJ Stock Higher From Here?
- Jun 12th, 2026 2:53 pm
JNJ Raised the Bar: So Why Is the Stock Standing Still?
- Jun 12th, 2026 1:14 pm
3 Stocks Estimated To Be Up To 47.8% Below Intrinsic Value
- Jun 12th, 2026 11:38 am
The Catch Hiding In Eli Lilly Stock's Growth Story
- Jun 12th, 2026 11:31 am
3 Stocks That Might Be Up To 39.8% Below Their Estimated Intrinsic Value
- Jun 12th, 2026 5:38 am
Forget JEPI, Goldman’s S&P Income ETF Has Beaten It by 42 Points Since Launch
- Jun 12th, 2026 5:23 am
AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend.
- Jun 12th, 2026 4:35 am
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
- Jun 12th, 2026 1:00 am
Up 45% Since 2024: 1 Glaring Reality That Makes AbbVie Stock a Hold at $225
- Jun 11th, 2026 12:22 pm
Why Did Wall Street Misprice JNJ Stock?
- Jun 11th, 2026 12:03 pm
Is AbbVie Inc. (ABBV) A Good Stock To Buy Now?
- Jun 11th, 2026 12:00 pm
3 Stocks That Might Be Priced Below Their Estimated Value In June 2026
- Jun 11th, 2026 11:38 am
Will Skyrizi & Rinvoq Continue to Drive AbbVie's Topline Through 2026?
- Jun 11th, 2026 9:26 am
Can Linzess Continue Driving IRWD's Revenue Growth Through 2026?
- Jun 11th, 2026 7:38 am
3 Stocks That Investors Might Be Undervaluing Based On Current Market Estimates
- Jun 11th, 2026 5:37 am
3 Dividend Stocks Built for Retirement to Buy in June
- Jun 10th, 2026 2:05 pm
Scroll